Cold Form Blister Packaging Market size was over USD 4.3 billion in 2023 and is estimated to reach USD 9.9 billion by the end of 2036, growing at a CAGR of 8.1% during the forecast period, i.e., 2024-2036. In 2024, the industry size of cold form blister packaging is estimated at USD 4.7 billion.
The cold form blister packaging market expansion is attributed to the increasing demand for secure and tamper-evident packaging in the pharmaceutical industry. With the rising need for reliable and protective packaging solutions for sensitive medications and drugs, cold form blister packaging has become a preferred choice due to its superior protection against environmental factors such as moisture, light, and oxygen. This enhanced protection helps in maintaining the efficiency and safety of pharmaceutical products, which is crucial for both manufactures and consumers.
The growing pharmaceutical sector’s focus on product safety, efficacy, and patient compliance continues to fuel the demand for cold form blister packaging. Pharmaceuticals such as high-value drugs, complex generics, and specialty medications often require cold form blister packaging to ensure protection against moisture and light. Thus the growing demand for pharmaceuticals drives the adoption of cold form blister packaging.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
8.1% |
|
Base Year Market Size (2023) |
USD 4.3 billion |
|
Forecast Year Market Size (2036) |
USD 9.9 billion |
|
Regional Scope |
|
Material (Oriented polyamide, Aluminum, Polyvinyl Chloride (PVC), Polypropylene (PP), Polyethylene (PE), Polyethylene Terephthalate (PET))
Aluminum segment is set to account for more than 45% cold form blister packaging market share by the end of 2036 on account of the increasing usage of aluminum for packaging. According to the International Aluminum Institute, the packaging industry's use of aluminum is expected to climb from 7.2 million tons in 2020 to 10.5 million tons in 2030, primarily led by the growing demand for canned drinks in countries such as China, Europe, and North America.
Aluminum cold form blister packaging is widely used in the pharmaceutical industry for packaging tablets, capsules, and other medications. Its ability to provide an impermeable barrier ensures that medicines are protected from contamination and degradation.
Application (Healthcare, Consumer Products, Electronics & Semiconductors, Food & Confectionery)
The healthcare segment in the cold form blister packaging market is projected to generate significant revenue over the coming years. The healthcare industry is subject to stringent regulations to ensure product safety and integrity. Cold form blister packaging meets these requirements by offering tamper-evident features and robust protection, which helps manufacturers comply with regulatory standards. Additionally, the increasing prevalence of chronic diseases, an aging population, and advancements in pharmaceutical products contribute to higher demand for packaging that ensures drug safety and extends shelf life.
Our in-depth analysis of the cold form blister packaging market includes the following segments:
|
Material |
|
|
Application |
|
APAC Market Statistics
Asia Pacific in cold form blister packaging market is expected to account for around 35% revenue share by 2036. The booming e-commerce industry in the region is a major driver of the market, fueled by the need for secure, compliant, and efficient packaging solutions for a wide range of products. For instance, the e-commerce industry in Asia Pacific was valued at USD 2980.1 billion in 2022. As e-commerce continues to grow, the demand for advanced cold form blister packaging is expected to rise accordingly.
Also, a noticeable change in packaging trends has been observed in Japan in recent years, primarily due to increased public awareness of environmental issues, and the growing need for medicine delivery devices including autoinjectors, transdermal patches, inhalers, and prefilled syringes, which call for specific packaging options.
With over 25% of all blisters packaging machine procedures performed annually worldwide, China is the country with the greatest consumption share of blister packaging machines for pharma. Along with this, China is the world's leading producer of PVC, which may augment the market demand for cold form blister packaging.
North American Market Analysis
The North America cold form blister packaging market is also predicted to have notable growth during the forecast period fueled by the increasing need for fast-moving consumer goods (FMCG), also called consumer packaged goods (CPG). For the majority of consumers in the region consumer packaged goods (CPG) are an essential component of daily living, which may boost the cold form blister packaging market share.
The existence of numerous producers of medical devices in the U.S. including Johnson & Johnson and Pfizer Inc., have converted to cold form blister packaging solutions used for over-the-counter items and prescriptions that need to be taken precisely, such as birth control pills.
In Canada, blister packaging is gaining traction as a packaging substitute due to the rising need from end-use industries including food, healthcare, consumer goods, and industrial items.
The cold form blister packaging market is dominated by key market players who are gaining traction in the market as several major companies are entering the industry by introducing improved technologies and making investments.
Author Credits: Abhishek Anil
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?